Article info

Download PDFPDF

Clinical utility of anti-interleukin 5 monoclonal therapy in asthma using a national, centralised, outcome-based system of drug access

Authors

  1. Correspondence to Dr Desmond M Murphy; desmond.murphy{at}hse.ie
View Full Text

Citation

O'Leary C, Schultz C, Walsh C, et al
Clinical utility of anti-interleukin 5 monoclonal therapy in asthma using a national, centralised, outcome-based system of drug access

Publication history

  • Received June 21, 2022
  • Accepted September 4, 2022
  • First published September 27, 2022.
Online issue publication 
September 27, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.